Stay updated on KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Sign up to get notified when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:24.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:48:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:25:14.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-11T22:21:33.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previous study record content with an access-denied screen.
    Difference
    19%
    Check dated 2026-09-20T19:56:28.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The status of the study shifted from Active, not recruiting to Completed as of 2026-09-04, and the prior recruiting indicator was removed on 2026-07-30. This update indicates that enrollment and study activities have concluded.
    Difference
    0.1%
    Check dated 2026-09-06T16:58:54.000Z thumbnail image

Stay in the know with updates to KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KarXT for Alzheimer's Psychosis: ADEPT-2 Clinical Trial page.